Abstract. The surfactant fraction (55,000-g pellet) of leukocyte-free rat bronchoalveolar lavage fluid contains factors that rapidly kill and lyse pneumococci. These factors were purified and identified biochemically by using a quantitative bactericidal test to monitor fractionation procedures. 91% of the antipneumococcal activity of rat surfactant was recovered in chloroform after extraction of rat surfactant with chloroform-methanol (Bligh-Dyer procedure). After chromatography on silicic acid with chloroform, acetone, and methanol, all detectable antibacterial activity (-80% of the initial activity) eluted with the neutral lipids in chloroform. When rechromatographed on silicic acid with hexane, hexane-chloroform, and chloroform, the antibacterial activity eluted with FFA. Thin-layer chromatography (TLC) established that the antibacterial activity was confined to the FFA fraction. Gas-liquid chromatography showed that the fatty acid fraction contained a mixture of long-chain FFA (C12 to C22) of which 66.7% were saturated and 32.4% were unsaturated. The quantity of TLC-purified FFA needed to kill 50% of 108 pneumococci under standardized conditions (one bactericidal unit) was 10.6±0.5 Ag. Purified FFA acted as detergents, causing release of [3H]choline from pneumococcal cell walls and increased bacterial cell membrane permeability, evidenced by rapid unloading of 3-0-[3H]methyl-Dglucose. FFA acting as detergents appear to account for the bactericidal and bacteriolytic activity of rat pulmonary surfactant for pneumococci.
standard histologic techniques, and the results indicate that staphylococci in the alveoli are killed predominantly by macrophages (1) (2) (3) (4) . These findings notwithstanding, alveolar macrophages often show poor chemotactic and phagocytic ability compared with peritoneal macrophages (5) (6) (7) and have weak intracellular killing activity in vitro (8, 9) . Recently, Nugent and Pesanti (10) monitored intraalveolar killing of staphylococci by use of a bronchoalveolar lavage technique, rather than by microscopic examination of fixed tissue sections, and obtained evidence that inhaled staphylococci are killed mainly outside alveolar macrophages. The reasons for the different results are not clear but presumably relate to the different sampling methods used. With nonstaphylococcal bacteria, it has been assumed that macrophages have a major role in pulmonary clearance, but this possibility has not been proven. We have demonstrated that three different serotypes of pneumococci with greatly different opsonic requirements and virulence in rats are killed intraalveolarly at essentially the same rate ("50% in 30 min), suggesting that alveolar killing of pneumococci does not require conventional opsonins (11) . In a search for extracellular bactericidal factors for pneumocci, we demonstrated that the surfactant fraction (55,000-g pellet) of leukocyte-free lavage of rats and other animal species contain heat and trypsin resistant factors that are rapidly bactericidal and lytic for pneumococci in vitro (12) . The present studies provide complete characterization of these extracellular bactericidal factors.
Methods
Solvents. Chloroform, methanol, acetone, hexane, and benzene (all high pressure liquid chromatography grade) were obtained from Fisher Scientific Co., Fair Lawn, NJ.
Animals. Male Sprague-Dawley rats (200 g or more) were obtained from Charles River Breeding Laboratories, Inc. (Wilmington, MA). Adult albino guinea pigs were obtained from Hilltop Laboratories (Scottsdale, PA). The animals were housed in filtered air units. Bronchoalveolar lavage. Lavage was carried out in rats as described elsewhere ( 13). In brief, rats were killed with an overdose of anesthetic (fluothane) and the lungs were lavaged in situ. A tracheotomy was made with a 22-gauge needle and a plastic catheter was inserted and secured with a tie. 5 ml of phosphate-buffered saline (PBS) (pH 7.4) was infused and withdrawn for two to three cycles. The PBS was composed of 8.5 g NaCl, 0.2 g KCl, 1 .05 g Na2HPO4, and 0.2 g KH2PO4 per liter. The fluid was chilled immediately in an ice bath and centrifuged at 160 g for 5 min to remove leukocytes. The surfactantcontaining fraction was prepared by centrifuging leukocyte-free fluid at 55,000 g for 20 min and removing the supernatant. Guinea pigs were killed and lavaged in the same manner as rats except 10 ml of PBS was used for lung lavage. Dogs were anesthetized with intravenous sodium thiamylal and lavaged with PBS through a catheter wedged into a bronchus. Lipolysis was evaluated by addition of radiolabeled phospholipids to the infusion fluid followed by fractionation on silicic acid and silica gel to detect the release of FFA. The lipids added were L-alpha-dipalmitoyl-[dipalmitoyl-1-'4C1 phosphatidylcholine, with a specific activity of 112 mCi/mmol and L-Il-[palmitoyl-l-'4C]lysopalmitoylphosphatidylcholine, with a specific activity of 55 mCi/mmol. Both were obtained from New England Nuclear (Boston, MA).
Bacteria. Type 25 Streptococcus pneumoniae was obtained from the American Type Culture Collection (ATCC 6325), Rockville, MD, passed monthly in mice, and stored in heat-inactivated rabbit serum at 4VC. Pneumococci were grown to log phase in brain-heart infusion broth containing 7% heat-inactivated rabbit serum over 5-6 h and washed once in PBS before bactericidal tests.
Type 25 pneumococci with radiolabeled cell walls were prepared as described previously (12) using a chemically defined medium and tritiated choline. In brief, pneumococci were grown overnight in synthetic medium with I MCi of [3H]methyl choline chloride per ml (80.0 Ci/mmol sp act, Sigma Chemical Co., St. Louis, MO). The radiolabeled bacteria (> 14,500 cpm/10' bacteria) were washed in PBS and used immediately. Release of label from cell walls was measured by centrifuging lipid-treated bacteria at 1,600 g for 20 min and taking up the pellets and the supernatant fluids separately in Aquasol-2 (New England Nuclear). Freed radiolabel in the experimental tubes was expressed as percentage of total cpm minus cpm for controls (bacteria in PBS alone).
Pneumococci were labeled internally with 3-O-[3H]methyl-D-glucose (80.0 Ci/mmol sp act, Sigma Chemical Co.) by incubating 1 MCi of tritiated 3-O-methyl-D-glucose in 0.1 ml of 0.1 mM unlabeled 3-0-methyl-D-glucose and 0.1 ml of 108 washed, log-phase bacteria in PBS for 30 min at 37°C. After four washes in PBS, the bacteria in 0.1 ml were incubated with 0.2 ml of lipid-containing sample at 37°C and the radioactivity released was determined by differential centrifugation and counting in Aquasol 2.
Bactericidal test. The bactericidal test was performed by incubating washed log-phase type 25 pneumococci (-IO' in 0.1 ml of PBS) with 0.2 ml of lipid-containing sample or with PBS (control) for 60 min at 37°C. Surviving bacteria in the control and test samples were then counted by plating 10-fold dilutions of the reaction mixture on 5% sheep blood agar in 5% CO2 overnight. The 50% bactericidal titer was determined with serial dilutions of test lipid prepared in chloroform, dried under nitrogen gas and dispersed in PBS with brief sonication. The percent of inoculum surviving at each dilution (in milliliters) was plotted on linear-log paper, and the dilution corresponding to 50% killing was interpolated graphically. The reciprocal of this dilution represented the 50% bacterial killing titer. A control tube to detect any antibacterial activity of solvent residues was included in most runs. Solvent controls were uniformly negative with high performance liquid chromatography-grade chemicals. Lipid extraction. Lipids were extracted from fresh, pooled pulmonary surfactant with a modified Bligh-Dyer procedure (14) . For each four rats in a pool the surfactant was suspended in 0.8 ml of PBS and 3 ml of chloroform-methanol (1:2) was added. The mixture was dispersed with sonication and chloroform (I ml) and water (I ml) were added with sonication after each addition. After centrifugation at 200 g for 5 min, the upper phase was discarded and the interphase was extracted again. The chloroform phases from the two extractions were pooled and dried with nitrogen gas. Total lipid weight was measured on a microbalance (Cahn Instruments, Inc., Cerritos, CA) and the lipid was dissolved in chloroform and stored at -70'C. Where indicated, heptadecanoic acid (C37:0) (Sigma Chemical Co.) was added to crude lavage preparations before extraction for quantitation of FFA.
Column chromatography. Silicic acid chromatography was carried out using standard methods with a column (5:1, height/diameter) containing 5 ml (3-4 g) of heat-activated silicic acid (Bio-Sil HA, 325 mesh, Bio-Rad Laboratories, Richmond, CA) and no more than 30 mg of lipid in 0. Separations, Inc., Clifton, NJ) were used. The solvent used for analytical plates was petroleum ether, diethyl ether, and acetic acid (90:10:1). Standards included cholesterol, stearic acid, mono-, di-, and triglycerides, and sterol (Sigma Chemical Co.). Preparative plates for batch isolation of FFA were used with chloroform, methanol, and ammonium hydroxide (66:10:2). Lipids were detected with 0.003% aqueous rhodamine. Plates were dried in a vacuum dessicator overnight and the area of the gel of interest was removed and eluted with chloroform, chloroformmethanol, 2: 1, and chloroform-methanol, 1:2 (solvent volume/powder volume, 2:1). Eluates were pooled, dried under nitrogen, and the residues were stored in chloroform at -70'C.
Gas-liquid chromatography (GLC). Fatty acids were methylated as described by Metcalf et al. (15) . In brief, lipid residues were dried under nitrogen gas, mixed with I ml benzene and I ml of 14% boron trifluoride in methanol (Sigma Chemical Co.) and heated for 30 min at 80'C. Samples were cooled, mixed with 0.5 ml water, and centrifuged at 200 g for 5 min. The organic phase was separated, dried, and dissolved in hexane for GLC. Chromatography was carried out on a glass coil column (1.8 m X 2.6 mm, i.d., Schimadzu GC-Mini 1, Schimadzu Scientific Instruments, MD).
Fatty acids. Purified fatty acids for chromatographic standards and for studies of antibacterial activity were obtained from Sigma Chemical Co. except for docosatetraenoic acid and docosahexaenoic acid, which were purchased from Nu Chek Prep, Inc., (Elysian, MN).
Results
Quantitation of antipneumococcal activity. Titration of the number of type 25 pneumococci surviving incubation in rat 1 . Abbreviations used in this paper: GLC, gas-liquid chromatography; TLC, thin-layer chromatography. bronchoalveolar lavage was used to monitor procedures for isolation and identification of antibacterial factors (Fig. 1) . Titration was most sensitive in the region of 50% bacterial killing, where small changes in the concentration of antibacterial substances caused easily measurable changes in the number of bacteria killed. The reciprocal of the dilution of antibacterial substance (in milliliters) that produced 50% killing of pneumococci was taken as the bacterial killing titer and one unit of bacterial killing activity was defined as the activity which killed half of 108 type 25 pneumococci under standardized conditions.
Antipneumococcal activity localized to surfactant lipids. It was demonstrated previously (12) that the antipneumococcal activity of leukocyte-free alveolar lavage fluid is located in the pellet obtained by centrifugation at .55,000 g (surfactantcontaining fraction) and is heat and trypsin resistant. These observations, which suggested the antibacterial factors are lipids, were substantiated by showing that most of the antibacterial activity can be extracted into chloroform. This finding was confirmed in the present work by extracting a preparation of pooled rat surfactant containing 16.0 units of antipneumococcal activity with chloroform-methanol (Bligh-Dyer procedure); 15.0 units (90.9% of the total) were recovered in chloroform and 1.5 units remained in aqueous-methanol. Extraction of the antibacterial factors from the surfactant pellet into chloroform eliminated the problem of loss of antipneumococcal activity noted previously with rat surfactant stored in aqueous media. The antibacterial activity of the extracted surfactant lipids stored at -70'C in chloroform was stable indefinitely.
Identification ofantibacterial lipids ofsurfactant. The pro- tocol indicated in Fig. 2 was followed in isolating antibacterial factors from rat lavage. Surfactant lipids that had been extracted in chloroform from leukocyte-free lavage fluid were weighed, fractionated on a silicic acid column that was eluted successively with chloroform, acetone, methanol, and the antibacterial titers of the fractions determined. As indicated in Table I with chloroform and methanol to recover the separated lipids, and the fractions tested for antipneumococcal activity. As indicated in Table I , the antibacterial activity was confined to the fraction corresponding to FFA. Controls to detect toxic effects of organic solvent residues on pneumococci were included throughout the procedure and were consistently negative. These data established that it was FFA in surfactant lipids that accounted for the antibacterial activity of rat bronchoalveolar lavage.
Quantitation of FFA in rat lavage. FFA in rat surfactant were identified and quantitated with GLC. Surfactant lipid was extracted into chloroform from leukocyte-free lavage fluid, weighed, and a known amount of heptadecanoic acid (C17:0) added. The neutral lipids were separated by elution with chloroform on silicic acid, and FFA were separated on preparative silica gel plates using chloroform, methanol, and ammonium hydroxide (66:10:2). FFA were eluted from the TLC plates and methylated for GLC. The results (Table II) 35 .5±1.6 ,g FFA/ml) ( Table II) .
Studies of lipolysis during lavage. To determine if FFA were released from surfactant lipids during lavage, dipalmitoyl phosphatidylcholine labeled with "'C in both palmitate residues or palmitoyl lysophosphatidylcholine labeled with 14C in the palmitate residue were added to the infusion fluid for lavage (PBS with 40 mM Na2CO3, pH 7.4). In the first experiment, 2.0 ,uCi of labeled dipalmitoyl phosphatidylcholine were mixed with 100 yg of the unlabeled phospholipid and dispersed in infusion fluid. Lavage fluids from two rats were pooled and incubated at room temperature for 30 min. The leukocytes were removed and the lipids in the supernatant were fractionated as usual. The leukocyte fraction contained 3.2% (693 cpm) of the recovered label with 96.8% (20,963 cpm) remaining in the supernatant. The surfactant-containing pellet from the leukocyte-free fluid had 10,719 cpm (49.5% of the total cpm) and 91.0% of these counts were extracted into chloroform by the Bligh-Dyer procedure. During fractionation on silicic acid all detectable cpm above background (8,813 cpm) eluted with methanol. Neither the chloroform nor acetone fractions contained detectable radiolabeled lipid. Thus, there was no evidence of lipolysis. In a second experiment 1.0 ,Ci of '4C-labeled palmitoyl lysophosphatidylcholine in 100 ,g of the unlabeled lysolipid was dispersed in infusion fluid and each of two rats was lavaged. The fluids were pooled, incubated at room temperature for 30 min, and the leukocytes were separated. The whole lavage contained 7,947 cpm (100%) with 3.6% of the total separating with the leukocytes and 43.3% of the cpm separating with the surfactant-containing pellet. In the BlighDyer extraction, 90.0% of the cpm in the surfactant fraction were extracted into chloroform. On silicic acid fractionation, all detectable cpm above background eluted with methanol, indicating that no FFA were released from the lysolipid. Antipneumococcal activity of pure FFA. To determine which FFA identified by GLC in rat surfactant were antibacterial, seven of the most abundant were tested alone and combined in proportions that simulated the natural material. Fatty acids were obtained commercially (-98% purity), dispersed and serially diluted in chloroform, and dried with nitrogen gas. To conform to the conditions previously used with lavage, the lipid residues were redispersed as well as possible with sonication in 0.2 ml PBS (saturated FFA did not disperse as well as unsaturated FFA). Washed, log-phase pneumococci (108 in 0.1 ml of PBS) were added, and the mixtures were incubated at 370C. The results (Fig. 3) Antibacterial spectrum ofFFA. The spectrum of antibacterial activity of a mixture of pure FFA stimulating rat lavage was determined. The results (Table IV) showed that FFA had doserelated antibacterial activity, which was greatest with pneumococci, group A and B streptococci, and unspeciated "respiratory" streptococci. The activity was less against group D streptococci and Staphylococcus aureus, and least with aerobic gram-negative bacilli (pseudomonas, enterobacter, serratia, and proteus). The data indicated that the spectrum of activity was greater with higher concentrations of FFA.
FFA in nonmurine surfactants. FFA in surfactant fractions of bronchoalveolar lavage fluids of dogs and guinea pigs were determined (Table V) . FFA in these two species were similar. Both saturated and unsaturated FFA were detected with the former having a slight preponderance. As in rats (Table II) palmitic acid was the most abundant saturated FFA with lesser percentages of myristic and stearic acids also present. Guinea pig and dog lavage showed higher percentages of oleic acid and less arachidonic acid and higher unsaturated FFA than rat surfactant. The amount of FFA in the surfactant preparations varied: mean FFA (expressed as percentage of total lipid) was less for guinea pigs (0.97%) and dogs (4.5%) than for rats (13.2%, Table II) .
Discussion
The present studies demonstrate that bronchoalveolar lavage of several animal species contains antibacterial, long chain FFA. Antibacterial activity of lipid fractions extracted from rat pulmonary surfactant and purified by silicic acid and silica gel chromatography were monitored quantitatively by titration of antipneumococcal activity. Only the neutral lipid fraction (17) (18) (19) and can act as antibacterial detergents in vitro (20, 21) , causing increased bacterial membrane permeability and autolytic lysis of pneumococci (12) , the phospholipid fraction of rat surfactant had no antipneumococcal activity. FFA were the only antibacterial factors detected in rat surfactant that could account for the detergent effects on pneumococci that we have observed with crude rat lavage fluid.
Fatty acids are well-known antimicrobial substances with activity in vitro against gram-positive and gram-negative bacteria (22) (23) (24) (25) (26) , fungi (27, 28) , and enveloped viruses, including influenza (29) (30) (31) (34, 35) showed that staphylococci, streptococci, and candida rapidly decreased in number after being deposited on normal skin, whereas acetone-washed skin allowed greater persistence of the microorganisms. When skin surface acetone extracts were replaced on washed skin, the increased bacterial counts were not seen. Aly et al. (34, 35) also demonstrated a direct correlation between the degree of killing of experimentally applied staphylococci, streptococci, and candida and degree of inhibition in vitro by acetone extracts of the skin surface. It has been suggested that FFA can affect the flora of the gastrointestinal tract. Polyunsaturated FFA and lysolecithin in the small intestine of pigs appear to prevent proliferation of orally administered Clostridium welchii (36) . Human fecal lipids contain a mixture of long chain FFA (C60, CI8 Ii, Ci8:2, and C,20), which are bactericidal for gonococci (37) , and rectal gonococcal isolates have been shown to be more resistant to fecal FFA than are cervical or urethral isolates, suggesting that there is selection ofgonococci in vivo based on FFA sensitivity.
FFA have been identified in vaginal secretions (38) and human breast milk (39) where they may have a role as antistaphylococcal agents. Also, it has been shown that acellular supernatants of pus from experimental subcutaneous abscesses are bactericidal for staphylococci and this activity is caused by a mixture of long chain FFA and lysolecithin (40) . Inasmuch as FFA have been found to play a significant role in host defenses of the skin and mucosal surfaces, their role in alveolar defenses warrants consideration.
The spectrum of antibacterial activity of FFA in vitro varies with chain length, the degree of unsaturation, the methods used to disperse the lipids, and other experimental variables (22) (23) (24) (25) (26) (41) (42) (43) (44) . In general, both gram-positive and gram-negative bacteria have an equal (and low) level of sensitivity to short chain (CIO and shorter) FFA. Long chain FFA have greater antibacterial activity, particularly against certain gram-positive bacteria, possibly because the outer membrane of gram-negative bacteria tends to block penetration of EFA (45) . The spectrum of antibacterial activity observed with pure FFA helps to explain the spectrum of antibacterial activity we observed with crude rat surfactant (12) ; the crude material is most active against certain gram-positive bacteria, such as pneumococci, and penicillin-sensitive streptococci and least active against aerobic gram-negative bacilli. In the present studies low concentrations (i.e., 75 ,ug/ml) of pure FFA prepared to simulate the naturally occurring FFA mixture in rat lavage had essentially the same spectrum of activity as previously reported for crude rat lavage (12) . Higher FFA concentrations (250 jsg/ml), however, also had some activity against staphylococci and gram-negative bacilli. The spectrum of activity possible in vivo would obviously depend on the concentration of FFA in the alveoli.
Although reported results have varied, unsaturated FFA appear more active than saturated FFA as antibacterial agents (24) . This is particularly true for chain lengths of 18 or more carbons and for gram-negative organisms. Our results are consistent with this observation, but in vitro results cannot be readily extrapolated to the situation in vivo. Our original evaluation of bactericidal activity of lavage was carried out in an aqueous system (12) and aqueous conditions were maintained in the present study. Saturated FFA disperse less well than unsaturated FFA in water and this fact may have accounted for the results.
The mechanism(s) by which FFA kill gram-positive or gram-negative bacteria are not known in detail. Lysis of the pneumococcal cell wall by detergents, although visually impressive, is not necessary for pneumococcal killing (12) . At suitable concentrations FFA can cause leakage and even lysis of bacterial cell membranes (46, 47) as well as various cellular metabolic effects, including inhibition of respiratory activity, effects on transportation of amino acids, and uncoupling of oxidative phosphorlization (48) (49) (50) . Although our present and previous work suggests that FFA in rat surfactant alter pneumococcal cell membrane permeability, the exact mechanism of killing is not known.
Pulmonary lavage, as obtained in the present studies, contains both bronchial and alveolar secretions and either might contribute to the mixture of FFA isolated from the surfactant fraction of lavage. we demonstrated previously that gradient-purified lamaller bodies, which are lipid structures produced only by the type II alveolar epithelial cell (and thus solely of alveolar origin), display the same antipneumococcal activity as crude rat lavage (12) . This fact suggests that the antibacterial activity in lavage comes from alveolar secretions. Also, mucus inactivates the antipneumococcal activity of lavage (12) , which makes it unlikely that the antibacterial activity comes from the bronchial tree where mucus is abundant.
FFA have been demonstrated in varying amounts in surfactant obtained by lavage from dogs (17, 19) humans (18) , and in the present studies, rats and guinea pigs. Studies indicate that the quantity of FFA in normal human surfactant is -3% of the total surfactant lipid (18) . Published studies on dog surfactant show variable amounts of FFA, ranging from 1 to 7% of the total surfactant lipid weight; the corresponding figure in the present study (4.5%) is in this range. The FFA in canine lavage identified by GLC in studies of Pfleger et al. (17) are very similar to the present results: palmitic acid (43% of the total) and oleic acid (27%) were the most abundant, with myristic (1%), palmitoleic (8%), stearic (7%), linoleic (5%), linolenic (2%), and C20 and higher FFA (8%) also present. The present study indicated that in comparison with dog lavage, rat lavage contained more FFA (mean, 13.2% of total surfactant lipid weight) and guinea pig contained less FFA (mean, 0.97% of total lipid). These results may explain our inability in earlier studies (12) to detect antipneumococcal activity with lavage from guinea pigs, whereas rat and canine lavage were active.
The amount of FFA detected with crude lavage in vitro varies even among different lavage preparations from animals of the same species, possibly due to varying contamination with mucus or proteins that can bind FFA. FFA are present in lipid extracts of supernatants of rat lavage fluids centrifuged at 55,000 g for 20 min (Coonrod, J. D., and M. Jarrells, unpublished data), indicating that this compartment needs to be studied to determine the total FFA content of different lavage fluids. Thus, the significance of differences in FFA content and antibacterial activity in vitro as far as host defenses in vivo is unknown.
The possibility that FFA in lavage are an artifact of the collection procedure, due perhaps to lipase activity of lavage constituents, cannot be excluded completely. On direct test with radiolabeled dipalmitoyl phosphatidylcholine or palmitoyl lysophosphatidylcholine added to the infusate, however, we could not detect release of FFA with lavage. Perhaps the best evidence that FFA in lavage are present in the alveoli in significant quantities comes from studies of alveolar macrophages. Resident alveolar macrophages of mice and rats maintained in "clean" conditions (under positive pressure ventilation) have few detectable complement receptors and display cell membrane abnormalities detectable by freeze-fracture microscopy suggestive of altered membrane fluidity (51, 52) . In contrast, murine monocyte/macrophages freshly arrived in the alveolar space in response to inflammatory stimuli, or resident peritoneal macrophages of rats, have morphologically normal membranes and easily detectable complement receptors (51, 53, 54) . Peritoneal macrophages incubated in the surfactant fraction of lavage develop reversible membrane abnormalities similar to those seen in rat resident alveolar macrophages (55) . These findings suggest that the abnormalities of resident alveolar macrophage membranes are due to factors in the alveolar microenvironment. Recently, we showed that FFA are the factors in rat surfactant responsible for membrane abnormalities and diminished detectability of complement receptors of alveolar macrophages (Coonrod, J. D., and M. Jarrells, unpublished data). These observations indicate that the effects of FFA on both alveolar leukocytes and microorganisms must be considered in future studies of alveolar host defenses.
